Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105585310> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2105585310 abstract "Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FLBackground: Cancer stem cells represent the cell population responsible for tumor initiation and progression. Resistance to cell death induced by cytotoxic agents is a characteristic shared by most identified cancer stem cells. In ovarian cancer, the CD44+/MyD88+ epithelial ovarian cancer (EOC) stem cells do not only represent the chemoresistant population, they are also able to repair the tumor and serve as tumor vascular progenitors. Targeting these cells is therefore necessary to improve treatment outcome. However, the previous demonstration that these cells are extremely chemoresistant, suggests that other forms of targeted therapy should be explored. We previously showed that the novel isoflavone derivative, NV-128, can induce caspase-independent cell death in ovarian cancer cells by inducing loss of mitochondrial membrane potential. We hypothesize that targeting mitochondrial bioenergetics may be a potent stimulus to induce cell death in the EOC stem cells. We demonstrate in this study that NV-128 is able to depress mitochondrial function leading to the activation of two independent pathways and cell death in these chemo-resistant cell population. Methods: A panel of CD44+/MyD88+ EOC stem cells was treated with NV-128 (1–10μg/ml). Inhibitory studies were done using the specific MEK inhibitor, U0126, or the ROS scavenger, MnTBAP. Mitochondrial integrity and function were assessed using Mitotracker Red, Mitotracker Green, MitoSox, and ApoSENSOR ADP/ATP kit. Cytoplasmic and mitochondrial fractions were prepared using the ApoAlertTM Cell Fractionation kit. Protein levels were determined using Western Blot.Results: NV-128 (10 μg/ml) significantly depressed mitochondrial function within 2h in all EOC stem cells tested. Treated cells had lower levels of ATP and Cox-IV, and higher levels of mitochondrial superoxide. Low cellular ATP led to mTOR inhibition through AMPKα1, while increased mitochondrial superoxide activated the mitochondrial MEK/ERK pathway and promoted Bax-dependent loss of mitochondrial membrane potential. Resulting cell death was characterized by Endo-G-induced but caspase-independent DNA fragmentation, as well as formation of autophagic vacuoles.Conclusion: We demonstrate that targeting the mitochondria in the EOC stem cells promotes a state of “cellular starvation” capable of activating two independent pathways: 1) AMPKα1 pathway leading to mTOR inhibition; and 2) mitochondrial MEK/ERK pathway leading to mitochondrial depolarization. The simultaneous activation of these pathways is a potent stimulus to induce cell death in cells. The demonstration that a compound can specifically target the mitochondria to induce cell death in this otherwise chemo-resistant cell population opens a new venue for treating ovarian cancer patients.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr LB-221. doi:10.1158/1538-7445.AM2011-LB-221" @default.
- W2105585310 created "2016-06-24" @default.
- W2105585310 creator A5032749726 @default.
- W2105585310 creator A5064908500 @default.
- W2105585310 creator A5075899098 @default.
- W2105585310 creator A5078106091 @default.
- W2105585310 creator A5088903979 @default.
- W2105585310 date "2011-04-15" @default.
- W2105585310 modified "2023-09-27" @default.
- W2105585310 title "Abstract LB-221: Depression of mitochondrial bioenergetics is a potent death stimulus in the ovarian cancer stem cells" @default.
- W2105585310 doi "https://doi.org/10.1158/1538-7445.am2011-lb-221" @default.
- W2105585310 hasPublicationYear "2011" @default.
- W2105585310 type Work @default.
- W2105585310 sameAs 2105585310 @default.
- W2105585310 citedByCount "0" @default.
- W2105585310 crossrefType "proceedings-article" @default.
- W2105585310 hasAuthorship W2105585310A5032749726 @default.
- W2105585310 hasAuthorship W2105585310A5064908500 @default.
- W2105585310 hasAuthorship W2105585310A5075899098 @default.
- W2105585310 hasAuthorship W2105585310A5078106091 @default.
- W2105585310 hasAuthorship W2105585310A5088903979 @default.
- W2105585310 hasConcept C121608353 @default.
- W2105585310 hasConcept C1491633281 @default.
- W2105585310 hasConcept C190283241 @default.
- W2105585310 hasConcept C2780427987 @default.
- W2105585310 hasConcept C2780932548 @default.
- W2105585310 hasConcept C28328180 @default.
- W2105585310 hasConcept C2908647359 @default.
- W2105585310 hasConcept C31573885 @default.
- W2105585310 hasConcept C502942594 @default.
- W2105585310 hasConcept C54355233 @default.
- W2105585310 hasConcept C55427017 @default.
- W2105585310 hasConcept C55493867 @default.
- W2105585310 hasConcept C71924100 @default.
- W2105585310 hasConcept C86803240 @default.
- W2105585310 hasConcept C94030615 @default.
- W2105585310 hasConcept C95444343 @default.
- W2105585310 hasConcept C96232424 @default.
- W2105585310 hasConcept C99454951 @default.
- W2105585310 hasConceptScore W2105585310C121608353 @default.
- W2105585310 hasConceptScore W2105585310C1491633281 @default.
- W2105585310 hasConceptScore W2105585310C190283241 @default.
- W2105585310 hasConceptScore W2105585310C2780427987 @default.
- W2105585310 hasConceptScore W2105585310C2780932548 @default.
- W2105585310 hasConceptScore W2105585310C28328180 @default.
- W2105585310 hasConceptScore W2105585310C2908647359 @default.
- W2105585310 hasConceptScore W2105585310C31573885 @default.
- W2105585310 hasConceptScore W2105585310C502942594 @default.
- W2105585310 hasConceptScore W2105585310C54355233 @default.
- W2105585310 hasConceptScore W2105585310C55427017 @default.
- W2105585310 hasConceptScore W2105585310C55493867 @default.
- W2105585310 hasConceptScore W2105585310C71924100 @default.
- W2105585310 hasConceptScore W2105585310C86803240 @default.
- W2105585310 hasConceptScore W2105585310C94030615 @default.
- W2105585310 hasConceptScore W2105585310C95444343 @default.
- W2105585310 hasConceptScore W2105585310C96232424 @default.
- W2105585310 hasConceptScore W2105585310C99454951 @default.
- W2105585310 hasLocation W21055853101 @default.
- W2105585310 hasOpenAccess W2105585310 @default.
- W2105585310 hasPrimaryLocation W21055853101 @default.
- W2105585310 hasRelatedWork W1974111650 @default.
- W2105585310 hasRelatedWork W2029654213 @default.
- W2105585310 hasRelatedWork W2045636354 @default.
- W2105585310 hasRelatedWork W2253199750 @default.
- W2105585310 hasRelatedWork W2312830844 @default.
- W2105585310 hasRelatedWork W2317146473 @default.
- W2105585310 hasRelatedWork W2320784755 @default.
- W2105585310 hasRelatedWork W2410510133 @default.
- W2105585310 hasRelatedWork W2492375574 @default.
- W2105585310 hasRelatedWork W2508228262 @default.
- W2105585310 hasRelatedWork W2617915670 @default.
- W2105585310 hasRelatedWork W2734341876 @default.
- W2105585310 hasRelatedWork W2766192711 @default.
- W2105585310 hasRelatedWork W2804958100 @default.
- W2105585310 hasRelatedWork W2885100421 @default.
- W2105585310 hasRelatedWork W2953519991 @default.
- W2105585310 hasRelatedWork W2955105754 @default.
- W2105585310 hasRelatedWork W3039432613 @default.
- W2105585310 hasRelatedWork W3045775113 @default.
- W2105585310 hasRelatedWork W3092321950 @default.
- W2105585310 isParatext "false" @default.
- W2105585310 isRetracted "false" @default.
- W2105585310 magId "2105585310" @default.
- W2105585310 workType "article" @default.